NYSE:MRK • US58933Y1055
Overall MRK gets a fundamental rating of 6 out of 10. We evaluated MRK against 192 industry peers in the Pharmaceuticals industry. MRK has an excellent profitability rating, but there are some minor concerns on its financial health. MRK has a decent growth rate and is not valued too expensively. MRK also has an excellent dividend rating. These ratings could make MRK a good candidate for dividend investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.69% | ||
| ROE | 36.71% | ||
| ROIC | 20.32% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 36.99% | ||
| PM (TTM) | 29.63% | ||
| GM | 77.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.17 | ||
| Altman-Z | 4.4 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.44 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.34 | ||
| Fwd PE | 22.63 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.29 | ||
| EV/EBITDA | 11.54 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.79% |
122.46
-1.47 (-1.19%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.79% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.34 | ||
| Fwd PE | 22.63 | ||
| P/S | 4.73 | ||
| P/FCF | 23.29 | ||
| P/OCF | 17.81 | ||
| P/B | 5.86 | ||
| P/tB | 20.33 | ||
| EV/EBITDA | 11.54 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.69% | ||
| ROE | 36.71% | ||
| ROCE | 23.54% | ||
| ROIC | 20.32% | ||
| ROICexc | 24.8% | ||
| ROICexgc | 44.78% | ||
| OM | 36.99% | ||
| PM (TTM) | 29.63% | ||
| GM | 77.69% | ||
| FCFM | 20.31% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.17 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 87.9% | ||
| Cap/Sales | 6.25% | ||
| Interest Coverage | 17.91 | ||
| Cash Conversion | 60.24% | ||
| Profit Quality | 68.56% | ||
| Current Ratio | 1.66 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 4.4 |
ChartMill assigns a fundamental rating of 6 / 10 to MRK.
ChartMill assigns a valuation rating of 6 / 10 to MERCK & CO. INC. (MRK). This can be considered as Fairly Valued.
MERCK & CO. INC. (MRK) has a profitability rating of 8 / 10.
The financial health rating of MERCK & CO. INC. (MRK) is 5 / 10.
The dividend rating of MERCK & CO. INC. (MRK) is 7 / 10 and the dividend payout ratio is 42.6%.